P710S100A4, a key player in plaque stabilization?
| Autor: | M Grigorian, Noona Ambartsumian, Marie-Luce Bochaton-Piallat, Jörg Klingelhöfer, Antonija Sakic, Brenda R. Kwak |
|---|---|
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | European Heart Journal. 40 |
| ISSN: | 1522-9645 0195-668X |
| Popis: | During atherosclerosis, intimal smooth muscle cells (SMCs) acquire a synthetic phenotype. We previously isolated spindle-shaped (S) and rhomboid (R) SMCs from porcine coronary artery. R-SMCs display the features of synthetic/dedifferentiated SMCs. S100A4 was identified as being a marker of R-SMCs in vitro and of intimal SMCs, in pig and man. S-SMCs were treated with multimeric recombinant S100A4, which resulted in partial transition from S- to R-phenotype and NFκB activation. Remarkably, treatment of S-SMCs with multimeric S100A4 and platelet-derived growth factor-BB (PDGF-BB) together induced a complete SMC transition toward a R-phenotype associated with NFκB activation compared with multimeric S100A4 or PDGF-BB alone, likely through toll-like receptor-4 (TLR-4). RNA sequencing showed strong upregulation of pro-inflammatory genes such as granulocyte-macrophage colony stimulating factor (GM-CSF) and matrix-matalloproteinase-3 (MMP-3, Figure A) when cells were treated with multimeric S100A4 and PDGF-BB together compared with multimeric S100A4 or PDGF-BB alone. In vivo, ApoE−/− mice were fed with high-cholesterol diet for 9 weeks. The 3 last weeks they were injected intraperitoneally with neutralizing monoclonal S100A4 antibody (clone 6B12, n=11) or with control IgG1 (n=12). Neutralization of extracellular S100A4 induced: decreased area of atherosclerotic lesions (Figure B), decreased necrotic core and cholesterol cleft, decreased number of CD68 positive cells and increased number of α-smooth muscle actin (Figure C) and smooth muscle myosin heavy chains-positive cells when compared to control groups. S100A4 and SMCs Our results indicate that extracellular S100A4 could be a new target to influence the evolution of atherosclerotic plaque, leading to plaque stabilization. Acknowledgement/Funding Swiss National Science Foundation grant #310030_166357/1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|